MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $61.56 million. The enterprise value is $54.02 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 41.88 million shares outstanding. The number of shares has increased by 17.53% in one year.
| Current Share Class | 41.88M |
| Shares Outstanding | 41.88M |
| Shares Change (YoY) | +17.53% |
| Shares Change (QoQ) | +13.47% |
| Owned by Insiders (%) | 10.49% |
| Owned by Institutions (%) | 3.33% |
| Float | 34.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.69 |
| P/TBV Ratio | 8.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 90.53
| Current Ratio | 90.53 |
| Quick Ratio | 89.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -123.33% and return on invested capital (ROIC) is -79.86%.
| Return on Equity (ROE) | -123.33% |
| Return on Assets (ROA) | -74.64% |
| Return on Invested Capital (ROIC) | -79.86% |
| Return on Capital Employed (ROCE) | -94.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$9.47M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.21% in the last 52 weeks. The beta is 1.75, so MIRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | +12.21% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 51.88 |
| Average Volume (20 Days) | 292,228 |
Short Selling Information
The latest short interest is 516,658, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 516,658 |
| Short Previous Month | 277,187 |
| Short % of Shares Out | 1.23% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.11M |
| Pretax Income | -6.86M |
| Net Income | -28.42M |
| EBITDA | n/a |
| EBIT | -7.11M |
| Earnings Per Share (EPS) | -$1.61 |
Full Income StatementBalance Sheet
The company has $7.54 million in cash and n/a in debt, giving a net cash position of $7.54 million or $0.18 per share.
| Cash & Cash Equivalents | 7.54M |
| Total Debt | n/a |
| Net Cash | 7.54M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 7.55M |
| Book Value Per Share | 0.19 |
| Working Capital | 7.51M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
